Healthcare edtech startup Virohan raises $7.5 M in ongoing Series B funding round
Mynavi Corporation is leading the ongoing Series B funding round for healthcare edtech startup Virohan, which has raised Rs 65 crore ($7.5 million). Virohan’s current investors, including Blume Ventures, Bharat Inclusive Technologies Seed Fund, and Rebright Partners, also participated in the round.
According to a press release from the company, the funding will expedite Virohan’s path to profitability through strategic talent expansion, operational efficiencies, and product innovation.
In addition to partnering with healthcare organizations like Lenskart, Medanta, Healthians, and Dr. Lal PathLabs to support student placements, Virohan offers undergraduate programs in allied healthcare, nursing, and healthcare management at universities like UPES, BBD University, CMR University, Assam Don Bosco University, and G.H. Raisoni University.
In order to support graduate employability, the seven-year-old company says it has trained over 13,000 healthcare students, collaborated with over 2,000 healthcare employers, and partnered with over 20 higher education institutions.
So far, Virohan has raised more than $25 million. Following the most recent share allocation, Mynavi Corporation will own 3.83% of the business, while Blume Ventures will maintain its position as the largest shareholder with 16.16%, according to media.
The business has not yet submitted its FY25 financial statements. Virohan’s operating revenue increased from Rs 10.65 crore in FY23 to Rs 21 crore in FY24, but its losses increased by 18% to Rs 22 crore.
